REFERENCES
- Hanberger H, Nilsson LE, Kihlstrom E, Mailer R. Postantibiotic effect of β-lactam antibiotics on Escherichia coli by bioluminescence assay of bacterial ATP. Antimicrob Agents Chemother 1990; 34 (1): 102–106.
- Bundtzen RW, Gerber AU, Cohn DL, Craig WA. Postantibiotic suppression of bacterial growth. Rev Infect Dis 1981; 3 (1): 28–37.
- Craig WA, Gudmunsson S. The postantibiotic effect. In: Lorian V, ed Antibiotics in laboratory medicine. 2nd ed. Baltimore: The Williams & Wilkins Co, 1986: 515–536.
- Gerber AU, Craig WA. Growth kinetics of respiratory pathogens after short exposure to ampicillin and erythromycin in vitro. J Antimicrob Chemother 1981; (Suppl C): 81-91.
- Gudmunsson S, Vogelman B, Craig WA. The in vivo postantibiotic effect of imipenem and other new antimicro-bials. J Antimicrob Chemother 1986; 18 (Suppl E): 67-73.
- Odenholt I, Isaksson B, Nilsson L, Cars O. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis 1989; 8 (2): 136–141.
- Vogelman B, Gudmunsson S, Turnidge I, Leggett I, Craig WA. In vivo postantibiotic effect in a thigh infection in neutropenic mice. J Infect Dis 1988; 157 (2): 287–298.
- Bustamante CI, Drusano GL, Tatem BA, Standiford GC. Postantibiotic effect of imipenem on Pseudomonas aerugi-nosa. Antimicrob Agents Chemother 1984; 26 (5): 678–682.
- Manek N, Andrews JM, Wise R. The postantibiotic effect of imipenem. J Antimicrob Chemother 1986; 18 (5): 641.
- Mac Kenzie FM, Milne KE, Gould IM. The post-expo-sure response of Enterobacteriaceae to ceftibuten. J Antimicrob Chemother 1999; 43 (1): 71–77.
- Gengo FM, Mannion TW, Nightingale CH, Schentag JJ. Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. J Antimicrob Chemother 1984;14 (6): 619–631.
- Odenholt-Tornqvist I, Lowdin E, Cars O. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob Agents Chemother 1991; 35 (9): 1834–1839.
- Sanders CC. In vitro activity of fourth generation cephalosporins against Enterobacteriaceae producing extend-ed-spectrum β-lactamases. J Chemother 1996; 8 (Suppl 2): 57–63.
- Bedenic B, Zagar Z. Extended-spectrum -lactamases in clinical isolates of Klebsiella pneumoniae from Zagreb, Croatia. J Chemother 1998; 10 (6): 449–459.
- Bedenic B, Randegger C, Stobberingh EE, Haechler H. Molecular epidemiology of extended-spectrum β-lactamases from Klebsiella pneumoniae strains isolated in Zagreb, Croatia. Eur J Clin Microbiol Infect Dis 2001; 20 (7): 505–508.
- National Committee for Clinical Laboratory standards. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically; approved standard. 5th ed. NCCLS document M7-A5, Wayne, Pennsylvania: NCCLS, 2000: 1-25.
- Krogstadt DJ, Moellering RCJr. Combinations of antibiotics. In: Lorian V, ed. Antibiotics in laboratory medicine. 2nd ed. Baltimore, Williams & Wilkins, 1986: 537-78.
- Gould IM. Do we need fourth generation cephalosporins? Clin Microbiol Infect 1999; 5 (Suppl 1): 1–5.
- Ronco E, Lawrence C, Nauciel C. Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spec-trum 13-lactamase. Pathol Biol 1998; 46 (8): 651–655.
- Nadler HL, Curby WA, Forgacs P, Rosenberg F. Comparison of electronic and viability counting methods for determination of postantibiotic effect of oxacillin on Staphylococcus aureus. Antimicrob Agents Chemother 1989; 33 (12): 2155–2156.
- Hanberger H, Svensson E, Nilsson M, Nilsson LE, Hoernsten EG, Mailer R. Effects of imipenem on Escherichia coli studied using bioluminescence, viable counting and microscopy. J Antimicrob Chemother 1993; 31 (2): 245–260.
- Libby JM Postantibiotic effect in Escherichia coli deter-mined with real-time metabolic monitoring. Antimicrob Agents Chemother 1998; 42 (1): 78–82.
- Gudmundsson S, Vogelman B, Craig WA. Decreased bactericidal activity during the period of the postantibiotic effect. J Antimicrob Chemother 1994; 34 (6): 921–930.